{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,15]],"date-time":"2025-11-15T16:26:00Z","timestamp":1763223960688,"version":"3.30.1"},"reference-count":21,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2001,12,25]],"date-time":"2001-12-25T00:00:00Z","timestamp":1009238400000},"content-version":"vor","delay-in-days":450,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["HIV Medicine"],"published-print":{"date-parts":[[2000,10]]},"abstract":"<jats:p><jats:bold>Background\u2003<\/jats:bold>The natural history of Kaposi's sarcoma (KS) is poorly documented. We attempted to identify factors predictive of progression and survival in HIV\u2010infected patients with KS and CD4<jats:sup>+<\/jats:sup>cell counts greater than 100\/\u03bcL.<\/jats:p><jats:p><jats:bold>Patients and Methods\u2003<\/jats:bold>We studied retrospectively 78 HIV\u2010infected patients diagnosed as having KS between 1989 and 1995. The following variables were assessed as potential predictors of progression and death, in a Cox proportional hazards model: age, sex, ethnic group, transmission group, site of the first KS lesions, duration of KS, concomitant opportunistic infections or malignancies, antiretroviral drug therapy (excluding protease inhibitors), antiherpes treatments, neutrophil counts, CD4<jats:sup>+<\/jats:sup>and CD8<jats:sup>+<\/jats:sup>cell counts, plasma HIV load, p24 antigenaemia, \u03b2<jats:sub>2<\/jats:sub>\u2010microglobulinaemia and immunoglobin A and G serum levels.<\/jats:p><jats:p><jats:bold>Results\u2003<\/jats:bold>During a median follow\u2010up of 22\u2003months (3\u201381\u2003months), KS progressed in 66 of the 78 patients. The median survival time after progression was 68\u2003months (9\u2013126\u2003months). Multivariate analysis identified only visceral KS, a high neutrophil count and a high serum immunoglobulin (Ig) level as independent predictors of progression (<jats:italic>P<\/jats:italic>\u2003&lt;\u20030.05). Previous and concomitant opportunistic diseases (<jats:italic>P<\/jats:italic>\u2003=\u20030.003) and low CD4<jats:sup>+<\/jats:sup>cell counts (<jats:italic>P<\/jats:italic>\u2003=\u20030.013) were independently associated with shorter survival; in contrast KS therapy did not independently influence survival.<\/jats:p><jats:p><jats:bold>Conclusion\u2003<\/jats:bold>Progression of KS is predicted by markers of KS severity, while overall survival is best predicted by markers of immunodeficiency (opportunistic diseases and the CD4<jats:sup>+<\/jats:sup>cell count).<\/jats:p>","DOI":"10.1046\/j.1468-1293.2000.00034.x","type":"journal-article","created":{"date-parts":[[2003,3,12]],"date-time":"2003-03-12T00:19:18Z","timestamp":1047428358000},"page":"232-237","source":"Crossref","is-referenced-by-count":10,"title":["Factors predictive of disease progression and death in AIDS\u2010related Kaposi's sarcoma"],"prefix":"10.1111","volume":"1","author":[{"given":"J\u2010P","family":"Spano","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y","family":"Salhi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D","family":"Costagliola","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W","family":"Rozenbaum","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P\u2010M","family":"Girard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2001,12,25]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-199812000-00009"},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-199807000-00002"},{"key":"e_1_2_6_4_2","unstructured":"Centers for Disease Control.revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults.MMWR1992; 19934E41 119."},{"key":"e_1_2_6_5_2","doi-asserted-by":"crossref","unstructured":"Krown SE Metroka C Wernz JC Kaposi's sarcoma in the acquired immune deficiency syndrome: a proposal for uniform evaluation response and staging criteria.J Clin Oncol1989;7 12011207.","DOI":"10.1200\/JCO.1989.7.9.1201"},{"key":"e_1_2_6_6_2","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.2517-6161.1972.tb00899.x","article-title":"Regression models and life tables","volume":"34","author":"Cox DR","year":"1972","journal-title":"J R Stat Soc"},{"key":"e_1_2_6_7_2","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1200\/JCO.1989.7.6.774","article-title":"Prognostic factors and staging classification of patients with epidemic Kaposi's sarcoma","volume":"7","author":"Chachoua A","year":"1989","journal-title":"J Clin Oncol"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1997.15.9.3085"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.2910080116"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19860415)57:8 <1657::AID-CNCR2820571304>3.0.CO;2-N"},{"key":"e_1_2_6_11_2","first-page":"361","article-title":"Kaposi's sarcoma associated with the acquired immunodeficiency syndrome. An analysis of 67 cases with a study of the prognostic factors","volume":"95","author":"Azon\u2010Masoliver A","year":"1990","journal-title":"Med Clin (Barc)"},{"key":"e_1_2_6_12_2","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1182\/blood.V67.3.666.666","article-title":"Prognostically significant classification of immune changes in AIDS with Kaposi's sarcoma","volume":"67","author":"Taylor J","year":"1986","journal-title":"Blood"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1111\/1523-1747.ep12875174"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(83)92300-0"},{"key":"e_1_2_6_15_2","doi-asserted-by":"publisher","DOI":"10.1097\/00126334-199109000-00008"},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-199801000-00004"},{"key":"e_1_2_6_17_2","doi-asserted-by":"crossref","unstructured":"Li\u00e8vre L Meyohas MC Costagliola D.Impact of opportunistic diseases on survival in HIV infected patients in France. Clinical Epidemiology Group from Centres d'Information et de soins de l'Immunodeficience Humaine.AIDS1999; 1992974E13 17891790.","DOI":"10.1097\/00002030-199909100-00029"},{"key":"e_1_2_6_18_2","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1093\/oxfordjournals.aje.a117481","article-title":"Changing patterns of Kaposi's sarcoma in Danish AIDS patients with complete follow up","volume":"15","author":"Lundgren JD","year":"1995","journal-title":"Am J Epidemiol"},{"key":"e_1_2_6_19_2","doi-asserted-by":"publisher","DOI":"10.1023\/A:1008261413274"},{"key":"e_1_2_6_20_2","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-199714000-00010"},{"key":"e_1_2_6_21_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.93.25.14862"},{"key":"e_1_2_6_22_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199701163360302"}],"container-title":["HIV Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1468-1293.2000.00034.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1046\/j.1468-1293.2000.00034.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,7]],"date-time":"2024-12-07T13:14:08Z","timestamp":1733577248000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1046\/j.1468-1293.2000.00034.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,10]]},"references-count":21,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2000,10]]}},"alternative-id":["10.1046\/j.1468-1293.2000.00034.x"],"URL":"https:\/\/doi.org\/10.1046\/j.1468-1293.2000.00034.x","archive":["Portico"],"relation":{},"ISSN":["1464-2662","1468-1293"],"issn-type":[{"type":"print","value":"1464-2662"},{"type":"electronic","value":"1468-1293"}],"subject":[],"published":{"date-parts":[[2000,10]]}}}